SMTL ID : 3coh.2 (1 other biounit)

Crystal structure of Aurora-A in complex with a pentacyclic inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 83H: 8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one(Non-covalent)

83H.1: 12 residues within 4Å: Chain A: L.16, V.24, A.37, L.71, L.87, E.88, Y.89, A.90, P.91, L.92, G.93, L.140 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.16, A:V.24, A:L.71, A:L.87, A:Y.89, A:L.140 Hydrogen bonds: A:A.90, A:A.90

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rawson, T.E. et al., A pentacyclic aurora kinase inhibitor (AKI-001) with high in vivo potency and oral bioavailability. J.Med.Chem. (2008)

Release Date

2009-02-17

Peptides

Serine/threonine-protein kinase 6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase 6

Related Entries With Identical Sequence